Doxorubicin Industry Research Report 2024-2030
Doxorubicin Market Doxorubicin Market Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Doxorubicin Market Size, Share & Trends ...
New AI model enhances clinical trial approval predictions by quantifying uncertainty
Researchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves ...
SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment
FDA confirms that SciSparc’s study may proceed following the application submission a month agoTEL AVIV, Israel, Sept. 23, 2024 (GLOBE ...
SciSparc Says FDA OKs Initiation Of Phase IIb Clinical Trial For SCI-110 To Treat Tourette Syndrome
Pharmaceutical company SciSparc Ltd. (SPRC) announced Monday that the U.S. Food and Drug Administration (FDA) has confirmed that its ...
Joplin Globe1h
Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
With the initiation of PALISADE-4 as planned, we have achieved another important milestone in our registration-directed PALISADE Phase 3 program for fasedienol, which has potential to deliver a ...
GEN2h
StockWatch: FDA Surprise Lifts Expectations for Applied’s Govorestat
Investors and analysts predict the FDA will approve Applied Therapeutics' lead candidate govorestat for classic galactosemia ...
Joplin Globe9h
Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that the U.S Food and Drug Administration (FDA) has cleared its investigational new drug (IND) ...
BioSpace10h
5 Schizophrenia Candidates Chasing BMS’ KarXT
As the FDA prepares to render a verdict on BMS’ closely watched schizophrenia drug, BioSpace takes a closer look at the ...